Filter
564
Filtered Results: 564
Text search:
Chagas
Featured
Recommendations
51
New Publications
97
Language
Document type
No document type
153
Studies & Reports
130
Guidelines
95
Strategic & Response Plan
37
Resource Platforms
35
Fact sheets
35
Manuals
30
Videos
15
Training Material
10
Brochures
8
Infographics
6
Situation Updates
5
Dashboards/Maps
3
App
1
Online Courses
1
Countries / Regions
Global
45
Latin America and the Carribbean
39
Brazil
27
Paraguay
22
Colombia
17
Argentina
17
Venezuela
12
Bolivia
8
Malawi
7
India
7
Mozambique
6
Angola
6
Pakistan
4
Kenya
3
Mexico
3
El Salvador
3
Ghana
3
Africa
3
Guinea-Bissau
3
Germany
3
South–East Asia Region
3
Rwanda
2
Syria
2
Iran
2
Nigeria
2
Zimbabwe
2
Jordan
2
Saudi Arabia
2
Western and Central Europe
2
Portugal
2
Lebanon
2
South Africa
2
Uganda
2
Sudan
2
Ethiopia
2
Iraq
2
Liberia
2
Guatemala
2
Benin
1
Sierra Leone
1
Chile
1
Albania
1
Senegal
1
Burkina Faso
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Italy
1
Tanzania
1
Tunisia
1
Djibouti
1
Namibia
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Libya
1
Botswana
1
Zambia
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
149
Clinical Guidelines
53
Public Health
35
Key Resources
20
Pharmacy & Technologies
14
Women & Child Health
11
Capacity Building
2
Toolboxes
NTDs
266
COVID-19
34
HIV
29
Rapid Response
19
Planetary Health
17
Zika
12
Ebola & Marburg
10
NCDs
10
Global Health Education
10
Mental Health
7
Caregiver
7
Refugee
5
Natural Hazards
4
TB
4
Disability
4
AMR
4
Pharmacy
3
Health Financing Toolbox
3
Cholera
2
Conflict
2
Polio
1
MSD Manual Patient information
The Lancet Microbe Volume 5, Issue 10100982October 2024
Chagas disease is a parasitic, systemic, and chronic disease caused by the protozoan Trypanosoma cruzi, with risk factors strongly link to low socioeconomic factors. Chagas disease is considered a neglected tropical disease. It is endemic in 21 countries in the Americas, although the migration of in...
In areas of Mexico, Central America, and South America, where the Trypanosoma cruzi parasite is present in triatomine bugs, improved housing and spraying insecticide inside housing to eliminate the bugs has significantly decreased the spread of Chagas disease. Screening of blood donations for Chagas...
La enfermedad de Chagas (ECha), resultado de la infección por el Trypanosoma cruzi, afecta varias poblaciones de las
zonas rurales de Suramérica y América Central. En los últimos años la enfermedad ha cobrado importancia epidemiológica no sólo porque se ha incrementado la detección de caso...
Objetivo general: Delinear las recomendaciones para la atención médica de niños, adolescentes y adultos infectados por el T. cruzi, en cualquiera de sus fases y formas clínicas. Se espera de esta forma optimizar el uso de recursos y mejorar la calidad de atención de los pacientes, con el fin de...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Chagas Disease (CD) affects 6–7 million people worldwide and isrelated topoverty-promo ting conditions. Chronic asymptomatic cases are mostly invisible tohealth systems. Aiming totranslate CD discoveries into education/information practices toraise alertness and empowerment ofaffected people; and ...
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera...
The Lancet Volume 403, Issue 10422p203-218January 13, 2024, Free Download with free registration
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
Chagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Th...
The Lancet Regional Health - Americas 2024;37: 100881
Published Online 13 September 2024 https://doi.org/10.1016/j.lana.2024. 100881
Outubro/2018 Nº 397
A century after its discovery, Chagas' disease still represents a major public health challenge in Latin America. Moreover, because of growing population movements, an increasing number of cases of imported Chagas' disease have now been detected in non-endemic areas, such as North America and some E...
La enfermedad de Chagas, también llamada tripanosomiasis americana, sigue siendo endémica en 21 países de América Latina. Sin embargo, como consecuencia de las migraciones, la urbanización, la intensificación del turismo, la modificación de las estrategias agrícolas y el cambio climático, l...
Chagas disease is caused by Trypanosoma cruzi. Infection is transmitted to humans when bitten by Triatominae (reduviid, kissing, or assassin) bugs in South and Central America, Mexico, and very rarely in the US. Less commonly, T. cruzi is transmitted via ingestion of sugar cane juice or food contami...
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d...
